Business Context and Reporting Period
Company: Primedex Health Systems, Inc. (operating as Radnet, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: July 31, 2006
Business Overview: The company operates 61 freestanding outpatient diagnostic imaging facilities in California, providing MRI, CT, PET, and other imaging services. Operations are consolidated with Beverly Radiology Medical Group III (BRMG), a professional corporation providing medical services.
Key Financial Metrics
| Metric | Three Months Ended July 31, 2006 | Nine Months Ended July 31, 2006 |
|---|---|---|
| Net Revenue | $40.3 million | $118.5 million |
| Income from Operations | $3.9 million | $12.6 million |
| Net Loss | $(1.4) million | $(4.6) million |
| Operating Cash Flow | N/A | $4.6 million |
| Working Capital | Deficit of $0.6 million | Deficit of $0.6 million |
| Stockholders' Deficit | $(74.6) million | $(74.6) million |
| Total Debt (Current + Long-Term) | ~$153 million | ~$153 million |
Note: Total debt includes approximately $146 million in notes payable, $16.1 million in subordinated debentures, and capital lease obligations. The company refinanced substantially all existing indebtedness in March 2006 with a new $161 million senior secured credit facility.
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased 11.5% for the quarter and 12.3% for the nine-month period compared to the prior year, driven by new capitation contracts, improved reimbursement rates, and facility expansions.
- Operating Expenses: Total operating expenses increased due to higher salaries (variable labor for increased volume), new facility rentals, and a $345,000 charge for equity-based compensation under the new SFAS 123(R) standard.
- Bad Debt Provision: The provision for bad debts increased significantly (from $0.9M to $2.0M for the quarter) due to increased revenue and timing of write-offs.
- Debt Restructuring: In March 2006, the company completed a refinancing of approximately $141 million in debt. This resulted in a $2.1 million net loss on debt extinguishment (including pre-payment penalties) and $5.6 million in deferred financing costs.
- Working Capital: The working capital deficit improved significantly from $143.4 million at October 31, 2005, to $0.6 million at July 31, 2006, primarily due to the reclassification of long-term debt to current liabilities prior to refinancing and the subsequent refinancing itself.
Guidance, Outlook, and Risks
Management Commentary and Outlook
Management believes it will obtain sufficient cash to satisfy obligations for the next twelve months through strategic plans and debt restructuring. The company is focusing on maximizing performance at existing facilities, profitable contracting, and expanding MRI/CT applications.
Material Events and Contingencies
- Radiologix Merger: On July 6, 2006, the company entered into an agreement to acquire Radiologix, Inc. for approximately $43 million in cash and 22.6 million shares of Primedex stock. Closing is contingent on securing a new $405 million credit facility.
- Regulatory Risk (DRA): The Deficit Reduction Act of 2005 will cap Medicare reimbursement for technical components of imaging services at the lower of the Part B fee schedule or the Hospital Outpatient Prospective Payment System (HOPPS) starting January 1, 2007. Management estimates this could have reduced 2005 revenue by approximately $4.5 million.
- Legal Settlement: The company settled a claim with Broadstream for $500,000, payable over 18 months.
Internal Controls
Management identified a material weakness in internal controls over financial reporting due to insufficient personnel resources and technical accounting expertise for non-routine matters. Remediation efforts, including hiring outside consultants, are underway.
Investor Verification Checklist
- Merger Financing: Verify the closing of the $405 million credit facility required to fund the Radiologix acquisition.
- Debt Covenants: Monitor compliance with the new credit facility's financial covenants, specifically the maximum leverage ratio and fixed charge coverage ratio.
- Medicare Reimbursement Impact: Assess the actual financial impact of the Deficit Reduction Act (DRA) reimbursement caps effective January 1, 2007.
- Internal Control Remediation: Confirm the effectiveness of new accounting controls and personnel to address the identified material weakness.
- Subordinated Debentures: Track the company's ability to retire or extend the $16.1 million subordinated debentures by the December 27, 2007 acceleration date.